Hyperion DeFi, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $41.2M
- Price
- $2.76
- % Change (Daily % change from the live per-ticker quote feed.)
- -2.46%
- Volume
- 86.1K
About
Operating from the United States, Hyperion DeFi, Inc. is a company undergoing a significant shift from its foundational work in ophthalmic drug-delivery, known as Optejet. Its current trajectory involves establishing itself as the inaugural U.S. firm on Nasdaq to hold a cryptocurrency treasury, predominantly denominated in HYPE tokens originating from the Hyperliquid blockchain. Furthermore, Hyperion DeFi oversees the "Kinetiq × Hyperion" validator, persists with its decentralized finance (DeFi) staking strategies, and continues to advance its Optejet UFD™ technology for ocular health.
Quick stats
Shares outstanding15.2M
Computed float14.5M
Float / shares95.4%
Key info
SectorHealthcare
IndustryMedical - Devices
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001682639
Websitehttps://hyperiondefi.com/
AI Summary
AI-generated1/14
majorbullishearnings
Hyperion DeFi Reports 2Q 2026 Financial Results with Another Record Quarterly Net Income and Strong Operating Momentum
Hyperion DeFi reported a second consecutive record quarter with Q2 Net Income of $31.0 million and Adjusted EBITDA of $53.7 million, bolstered by a rising HYPE token price and a growing digital asset treasury.
Operational metrics showed resilience with Adjusted Gross Profit increasing 20% quarter-over-quarter to $1.15 million, driven by staking yield and validator commissions, while operating expenses excluding stock-based comp declined 46% year-over-year.
Strategically, the company executed the sale of its remaining legacy life sciences IP to Arctic Vision and announced new HAUS agreements with Entropy and Skew to redeploy 1 million HYPE tokens into HIP-3 and HIP-4 market deployments.
Red flags
- GAAP Revenue ($358k) is negligible compared to Net Income ($31M), indicating earnings are heavily dependent on mark-to-market crypto asset appreciation rather than core business sales.
- Adjusted Net Operating Cash Flow remained negative at ($2.1M) despite record accounting profits.
- Guidance for Adjusted Net Operating Cash Flow to 'flip positive by end of 2026' suggests ongoing cash burn from operations.